20th week of 2019 patent applcation highlights part 11 |
Patent application number | Title | Published |
20190142882 | MICROBIAL PRODUCTION OF PURE SINGLE STRANDED NUCLEIC ACIDS | 2019-05-16 |
20190142883 | ONCOLYTIC VIRUSES TARGETING STAT3 | 2019-05-16 |
20190142884 | METHOD OF REDUCING STRESS AND ANXIETY IN EQUINES | 2019-05-16 |
20190142885 | ANTIOXIDANT COMPOSITION COMPRISING SARGASSUM SERRATIFOLIUM EXTRACT OR FRACTION THEREOF AS ACTIVE INGREDIENT | 2019-05-16 |
20190142886 | Ecklonia cava extract and a pharmaceutical composition for preventing or treating vascular diseases comprising the same as an active ingredient | 2019-05-16 |
20190142887 | CHEMOTHERAPEUTIC COMPOUNDS, PRODUCTION METHODS AND APPARATUSES THEREFOR, AND METHODS OF CANCER TREATMENT | 2019-05-16 |
20190142888 | PHYTOCANNABINOID TOPICAL COMPOSITIONS FOR RELEIVING PAIN | 2019-05-16 |
20190142889 | METHOD FOR IMPROVING MITOCHONDRIA AND METHOD FOR PROMOTING CELL DIVISION OF STEM CELL | 2019-05-16 |
20190142890 | DIETARY SUPPLEMENT DERIVED FROM THE SENEGALIA PLANT | 2019-05-16 |
20190142891 | FERMENTATION PRODUCT OF MUNG BEAN HULL AND USES OF THE SAME | 2019-05-16 |
20190142892 | CHEMOSYNTHETIC CYCLO-HEPTA MODIFIED PEPTIDE CAPABLE OF INHIBITING TOXIN OF STAPHYLOCOCCUS AUREUS AND USE THEREOF | 2019-05-16 |
20190142893 | Electron, Radical, or Reactive Oxygen Species-Scavenging Agent Based Therapy of Inborn Errors of Fatty Acid Oxidation and Oxidative Phosphorylation | 2019-05-16 |
20190142894 | PEPTIDE HAVING EFFECTS OF INCREASING TELOMERASE ACTIVITY AND EXTENDING TELOMERE, AND COMPOSITION CONTAINING SAME | 2019-05-16 |
20190142895 | METHODS OF DIAGNOSIS, SELECTION, AND TREATMENT OF DISEASES AND CONDITIONS CAUSED BY OR ASSOCIATED WITH METHANOGENS | 2019-05-16 |
20190142896 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF RADIATION-RELATED DISORDERS | 2019-05-16 |
20190142897 | COMPOSITION FOR IMPROVING MUSCULAR FUNCTION OR FOR ENHANCING EXERCISE PERFORMANCE COMPRISING VIGNA ANGULARIS VAR. ANGULARIS | 2019-05-16 |
20190142898 | Peptides Of Syndecan-1 For Inhibiting Angiogenesis | 2019-05-16 |
20190142899 | TREATMENT OF ISCHEMIA REPERFUSION INJURY USING ALPHA-2 MACROGLOBULIN | 2019-05-16 |
20190142900 | COMPOSITIONS OF MUSCLE STIMULATED MYOKINES AND METHODS OF USE THEREOF | 2019-05-16 |
20190142901 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING TYPE 1 DIABETES USING A BIOLOGIC RESPONSE MODIFIER IN COMBINATION WITH ONE OR MORE ISLET OR BETA CELL REGENERATION OR REPLACEMENT THERAPIES | 2019-05-16 |
20190142902 | METHOD AND COMPOSITION FOR INCREASING CARDIAC INFLOW | 2019-05-16 |
20190142903 | Calcitonin Mimetics for Treating Diseases and Disorders | 2019-05-16 |
20190142904 | ACYLATED GLP-1/GLP-2 DUAL AGONISTS | 2019-05-16 |
20190142905 | PEPTIDE-OLIGOUREA FOLDAMER COMPOUNDS AND METHODS OF THEIR USE | 2019-05-16 |
20190142906 | INSULIN RECEPTOR PARTIAL AGONISTS AND GLP-1 ANALOGUES | 2019-05-16 |
20190142907 | LYOPHILIZED RECOMBINANT VWF FORMULATIONS | 2019-05-16 |
20190142908 | LYOPHILIZED RECOMBINANT VWF FORMULATIONS | 2019-05-16 |
20190142909 | VIRAL VECTORS COMPRISING RDH12 CODING REGIONS AND METHODS OF TREATING RETINAL DYSTROPHIES | 2019-05-16 |
20190142910 | METHODS OF DEBRIDEMENT OF CHRONIC WOUNDS | 2019-05-16 |
20190142911 | NOVEL COMPOSITIONS FOR THE TREATMENT OF CANCER | 2019-05-16 |
20190142912 | HIGH FREQUENCY APPLICATION OF BOTULINUM TOXIN THERAPY | 2019-05-16 |
20190142913 | GRP78 ANTAGONIST THAT BLOCK BINDING OF RECEPTOR TYROSINE KINASE ORPHAN RECEPTORS AS IMMUNOTHERAPY ANTICANCER AGENTS | 2019-05-16 |
20190142914 | NOVEL FUSION PROTEINS FOR TREATING INFLAMMATORY DISEASES | 2019-05-16 |
20190142915 | OCULAR DELIVERY OF CELL PERMEANT THERAPEUTICS FOR THE TREATMENT OF RETINAL EDEMA | 2019-05-16 |
20190142916 | BIOMARKERS AND IMMUNOGENIC COMPOSITIONS FOR FILARIAL PARASITES | 2019-05-16 |
20190142917 | AN IMMUNOGENIC COMPOSITION FOR THE TREATMENT OF CANCER AND METHODS OF PREPARING THE SAME | 2019-05-16 |
20190142918 | CANCER VACCINES | 2019-05-16 |
20190142919 | PLIF MULTIMERIC PEPTIDES AND USES THEREOF | 2019-05-16 |
20190142920 | DNA Monoclonal Antibodies Targeting Checkpoint Molecules | 2019-05-16 |
20190142921 | COMPOSITIONS AND METHODS FOR THE EXPRESSION OF EUKARYOTIC OLIGOSACCHARIDES ON BACTERIAL OUTER MEMBRANE VESICLES | 2019-05-16 |
20190142922 | GROUP B STREPTOCOCCUS POLYSACCHARIDE-PROTEIN CONJUGATES, METHODS FOR PRODUCING CONJUGATES, IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATES, AND USES THEREOF | 2019-05-16 |
20190142923 | Controlled Release Vaccines and Methods of Treating Brucella Diseases and Disorders | 2019-05-16 |
20190142924 | DNA CONSTRUCTS FOR MANUFACTURING BIO-THERAPUETIC POLYPEPTIDES FOR USE IN ANIMAL VACCINES AND THERAPEUTICS | 2019-05-16 |
20190142925 | HPV PARTICLES AND USES THEREOF | 2019-05-16 |
20190142926 | UNIVERSAL VACCINE FOR VIRAL DISEASES | 2019-05-16 |
20190142927 | LOW-ADDITIVE INFLUENZA VACCINES | 2019-05-16 |
20190142928 | Liposome compositions comprising an adjuvant that activates or increases the activity of TLR2 and uses thereof | 2019-05-16 |
20190142929 | INFLUENZA VACCINE REGIMENS FOR PANDEMIC ASSOCIATED STRAINS | 2019-05-16 |
20190142930 | Influenza Vaccines | 2019-05-16 |
20190142931 | HEMAGGLUTININ POLYPEPTIDES, AND REAGENTS AND METHODS RELATING THERETO | 2019-05-16 |
20190142932 | A Buffer Free, Acid Stable Low Dose Volume Rotavirus Vaccine | 2019-05-16 |
20190142933 | THERAPEUTIC HPV VACCINE COMBINATIONS | 2019-05-16 |
20190142934 | Method and System for Protecting Honey Bees, Bats and Butterflies From Neonicotinoid Pesticides | 2019-05-16 |
20190142935 | Formulation Containing TLR Agonist and Methods of Use | 2019-05-16 |
20190142936 | DRY SOLID ALUMINUM ADJUVANT-CONTAINING VACCINES AND RELATED METHODS THEREOF | 2019-05-16 |
20190142937 | VACCINES WITH BIOMOLECULAR ADJUVANTS | 2019-05-16 |
20190142938 | TRIPLE COMBINATION THERAPY FOR TREATING INFLAMMATORY BOWEL DISEASE | 2019-05-16 |
20190142939 | COMBINATION THERAPY FOR INDUCING IMMUNE RESPONSE TO DISEASE | 2019-05-16 |
20190142940 | Method and system for effecting changes in pigmented tissue | 2019-05-16 |
20190142941 | BCL-XL Inhibitory Compounds Having Low Cell Permeability and Antibody Drug Conjugates Including the Same | 2019-05-16 |
20190142942 | PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM | 2019-05-16 |
20190142943 | PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM | 2019-05-16 |
20190142944 | INJECTABLE IBUPROFEN FORMULATION | 2019-05-16 |
20190142945 | FLUORESCEIN AND BENOXINATE COMPOSITIONS | 2019-05-16 |
20190142946 | RADIOPAQUE POLYMERS | 2019-05-16 |
20190142947 | COMPOSITION AS AUXILIARY MEANS FOR ORAL MEDICATION | 2019-05-16 |
20190142948 | AQUEOUS BASED CAPSAICINOID FORMULATIONS AND METHODS OF MANUFACTURE AND USE | 2019-05-16 |
20190142949 | COVALENT CONJUGATES | 2019-05-16 |
20190142950 | Reversible Covalent Linkage of Functional Molecules | 2019-05-16 |
20190142951 | INFLUENZA ANTIGEN DELIVERY VECTORS AND CONSTRUCTS | 2019-05-16 |
20190142952 | MODIFIED RELEASE FORMULATIONS CONTAINING DRUG-ION EXCHANGE RESIN COMPLEXES | 2019-05-16 |
20190142953 | Dendrimer-Drug Conjugates, Hydrogel Compositions, and Methods | 2019-05-16 |
20190142954 | POLYMER-BONDED CA4 PHARMACEUTICAL COMPOUND AND PREPARATION METHOD THEREFOR | 2019-05-16 |
20190142955 | PHARMACEUTICAL COMPOSITION CONTAINING MACROMOLECULAR DRUG | 2019-05-16 |
20190142956 | COMPOSITIONS AND METHODS FOR THE INHIBITION OF FIBROSIS | 2019-05-16 |
20190142957 | STABLE COMPOSITIONS OF PEGYLATED CARFILZOMIB COMPOUNDS | 2019-05-16 |
20190142958 | THERAPEUTIC PROTEINS WITH INCREASED HALF-LIFE AND METHODS OF PREPARING SAME | 2019-05-16 |
20190142959 | HYALURONIC ACID DERIVATIVES INTO WHICH CATIONIC AND HYDROPHOBIC GROUPS ARE INTRODUCED | 2019-05-16 |
20190142960 | FUCOIDAN NANOGELS AND METHODS OF THEIR USE AND MANUFACTURE | 2019-05-16 |
20190142961 | ASH1L DEGRADERS AND METHODS OF TREATMENT THEREWITH | 2019-05-16 |
20190142962 | RECEPTOR TARGETING CONSTRUCTS AND USES THEREOF | 2019-05-16 |
20190142963 | FGF21 C-TERMINAL PEPTIDE OPTIMIZATION | 2019-05-16 |
20190142964 | DENDRIMER DELIVERY SYSTEM AND METHODS OF USE THEREOF | 2019-05-16 |
20190142965 | HYDROGEL FOR ENGINEERED IMMUNE RESPONSE TO D-CHIRALITY PEPTIDES | 2019-05-16 |
20190142966 | Functionalized Nanoparticles and Compositions for Cancer Treatment and Methods | 2019-05-16 |
20190142967 | Immunomodulatory Oncolytic Adenoviral Vectors, and Methods of Production and Use Thereof for Treatment of Cancer | 2019-05-16 |
20190142968 | COMPOSITIONS AND METHODS FOR SELECTIVE INHIBITION OF GRAINYHEAD-LIKE PROTEIN EXPRESSION | 2019-05-16 |
20190142969 | ISL1-Based Gene Therapy to Treat Hearing Loss | 2019-05-16 |
20190142970 | LIVER-SPECIFIC CONSTRUCTS AND METHODS OF USE THEREOF | 2019-05-16 |
20190142971 | FORMULATION AND DELIVERY OF MODIFIED NUCLEOSIDE, NUCLEOTIDE, AND NUCLEIC ACID COMPOSITIONS | 2019-05-16 |
20190142972 | Compositions and Methods for Treatment of Diseases Associated with Trinucleotide Repeats in Transcription Factor Four | 2019-05-16 |
20190142973 | ENGINEERED NUCLEASES USEFUL FOR TREATMENT OF HEMOPHILIA A | 2019-05-16 |
20190142974 | METHODS AND COMPOSITIONS FOR ATTENUATING ANTI-VIRAL TRANSFER VECTOR IGM RESPONSES | 2019-05-16 |
20190142975 | EVASION OF NEUTRALIZING ANTIBODIES BY A RECOMBINANT ADENO-ASSOCIATED VIRUS | 2019-05-16 |
20190142976 | COMPOSITIONS AND METHODS FOR ASSESSING GUT FUNCTION | 2019-05-16 |
20190142977 | GADOLINIUM-BASED CONTRAST AGENTS FOR SENSITIVE DETECTION OF Zn2+ WITH MRI | 2019-05-16 |
20190142978 | METHODS FOR MAKING ULTRASOUND CONTRAST AGENTS | 2019-05-16 |
20190142979 | CONTRAST MEDIUM AND METHODS INVOLVED IN PREPARATION FOR THE DETERMINATION OF PATENCY OF CONDUITS | 2019-05-16 |
20190142980 | CELLS LOADED WITH GOLD NANOPARTICLES FOR USE IN THE DIAGNOSIS AND/OR TREATMENT OF MELANOMA | 2019-05-16 |
20190142981 | STERILIZING APPARATUS | 2019-05-16 |